ProQR Therapeutics

📍 Leiden, Netherlands🗓 Founded 2012👥 137 employees💰 Last funded Mar 2014
Biotechnology Research🌐 proqr.com
Website LinkedIn
Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary Axiomer RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of patients and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
2
Frequently asked questions
Who invested in ProQR Therapeutics?
ProQR Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did ProQR Therapeutics last raise funding?
The most recent investment in ProQR Therapeutics recorded on gritt.io was in March 2014.
When was ProQR Therapeutics founded?
ProQR Therapeutics was founded in 2012.
What industry is ProQR Therapeutics in?
ProQR Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is ProQR Therapeutics based?
ProQR Therapeutics is headquartered in Leiden, Netherlands.